Stockscreener 앱 받기
376.37
0.38%
1.43
시간 외 거래:
376.43
0.06
+0.02%
전일 마감가:
$374.94
열려 있는:
$377
하루 거래량:
1.19M
Relative Volume:
0.98
시가총액:
$143.66B
수익:
$23.82B
순이익/손실:
$2.92B
주가수익비율:
49.85
EPS:
7.55
순현금흐름:
$4.02B
1주 성능:
-4.17%
1개월 성능:
-4.11%
6개월 성능:
-3.84%
1년 성능:
+17.76%
1일 변동 폭
$373.72
$381.34
1주일 범위
$372.32
$384.46
52주 변동 폭
$320.78
$406.19
스트라이커 Stock (SYK) Company Profile
명칭
Stryker Corp
전화
(269) 385-2600
주소
1941 STRYKER WAY, PORTAGE, MI
SYK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
376.37 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
ABT
Abbott Laboratories
|
132.06 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.96 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
MDT
Medtronic Plc
|
91.24 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.93 | 46.11B | 5.69B | 4.15B | 623.10M | 6.95 |
스트라이커 Stock (SYK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 재개 | Citigroup | Buy |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | 개시 | Wolfe Research | Outperform |
| 2024-05-30 | 개시 | Goldman | Neutral |
| 2024-05-22 | 업그레이드 | Needham | Hold → Buy |
| 2024-01-31 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | 개시 | ROTH MKM | Buy |
| 2023-09-05 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-25 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-28 | 업그레이드 | Edward Jones | Hold → Buy |
| 2022-07-21 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2022-07-11 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-13 | 개시 | Truist | Hold |
| 2022-03-16 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | 재개 | Evercore ISI | Outperform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2022-01-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | 개시 | Loop Capital | Buy |
| 2021-09-14 | 재개 | Raymond James | Mkt Perform |
| 2021-07-28 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-10-06 | 개시 | Northland Capital | Market Perform |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-13 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-04-01 | 다운그레이드 | Goldman | Buy → Sell |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Buy |
| 2020-01-08 | 개시 | SunTrust | Hold |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | 재확인 | BTIG Research | Buy |
| 2019-11-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-10-30 | 재확인 | BofA/Merrill | Buy |
| 2019-07-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-01-30 | 재확인 | Canaccord Genuity | Buy |
| 2019-01-03 | 개시 | Deutsche Bank | Buy |
| 2019-01-02 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-08-16 | 개시 | BTIG Research | Buy |
| 2018-06-27 | 개시 | Bernstein | Mkt Perform |
| 2018-04-27 | 재확인 | Stifel | Buy |
모두보기
스트라이커 주식(SYK)의 최신 뉴스
Fed. Circ. Affirms PTAB Ax Of Bone Fusion Device Patents - Law360
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital - GlobeNewswire Inc.
Berkshire Unit Keeps Win Over Two Stryker Joint-Plate Patents - Bloomberg Law News
Stryker declares quarterly dividend of $0.84 per share - Investing.com
Stryker declares an $0.84 per share quarterly dividend - Yahoo Finance
Stryker raises 2025 sales, earnings guidance again after strong quarter - Crain's Grand Rapids
Stryker Corporation (NYSE:SYK) Not Flying Under The Radar - 富途牛牛
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat - Investing.com Canada
Citizens JMP reiterates Market Perform rating on Stryker stock after Q2 beat By Investing.com - Investing.com South Africa
Fund Update: Mesirow Financial Investment Management, Inc. added 43,487 shares of STRYKER ($SYK) to their portfolio - Quiver Quantitative
Truist Securities raises Stryker stock price target to $415 on solid results By Investing.com - Investing.com South Africa
Truist Securities raises Stryker stock price target to $415 on solid results - Investing.com
Stryker price target raised to $415 from $410 at Truist - TipRanks
What makes Stryker Corporation stock price move sharplyCapitalize on fast-moving stock opportunities - Jammu Links News
Does Stryker Corporation stock perform well during market downturnsIdentify undervalued stocks poised to rally - Jammu Links News
Why We're Not Concerned About Stryker Corporation's (NYSE:SYK) Share Price - 富途牛牛
Stryker Corporation (NYSE:SYK) Q2 2025 Earnings Call Transcript - Insider Monkey
Stryker Corp Reports Strong Q2 2025 Earnings Growth - The Globe and Mail
Stryker Corp’s Earnings Call Highlights Robust Growth - TipRanks
Stryker (SYK) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Stryker (SYK) Raises Guidance As Sales Reach US$6 Billion In Strong Q2 - Yahoo Finance
Stryker (SYK) Analyst Rating Update: Wells Fargo Raises Price Ta - GuruFocus
Stryker (SYK) Receives Price Target Boost from Baird - GuruFocus
Stryker price target raised to $438 from $421 at UBS - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $407 to $456 - 富途牛牛
Zimmer Biomet Holdings, Inc. shares fall 1.57% intraday as Stryker reports strong Q2 earnings. - AInvest
Stryker Remains on Pace to Benefit From a String of New Product Launches - Morningstar
Stryker lowers expected tariff impact to $175M - Yahoo Finance
Stryker price target raised to $450 from $436 at Baird - TipRanks
Stryker raises 2025 outlook amid 17.3% medical surgery and neurotechnology unit rise - Yahoo Finance
Needham Raises Price Target for Stryker (SYK) to $448, Maintains Buy Rating | SYK Stock News - GuruFocus
Why Stryker’s Stock is Gaining Momentum - TipRanks
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges - Yahoo Finance
Stryker Corp (SYK) Q2 2025 Earnings Call Highlights: Strong Growth Amid Supply Chain Challenges By GuruFocus - Investing.com Canada
Stryker: Q2 Earnings Snapshot - Greenwich Time
Earnings call transcript: Stryker Q2 2025 beats EPS and revenue forecasts - Investing.com
Stryker shares tumble despite strong Q2 results and raised guidance By Investing.com - Investing.com South Africa
Stryker shares tumble despite strong Q2 results and raised guidance - Investing.com
Stryker (NYSE:SYK) Surprises With Q2 Sales But Stock Drops - Yahoo Finance
Stryker Lifts Guidance on Improving Tariff Outlook - 富途牛牛
Stryker Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Stryker (SYK) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Stryker earnings beat by $0.06, revenue topped estimates - Investing.com
Stryker Corp. Exceeds Expectations with Strong Q2 EarningsNews and Statistics - IndexBox
Stryker Corp (SYK) Q2 2025 Earnings: EPS at $2.29 Misses Estimates, Revenue Hits $6.0 Billion Surpassing Expectations - GuruFocus
Stryker reports second quarter 2025 operating results - The Manila Times
Grant pays for Stryker building demolition - Bryan Times
What institutional investors are buying Stryker Corporation stockAI Powered Review For 2025 - Jammu Links News
Colonoscopy Market Top PlayersOlympus Corporation, Stryker, - openPR.com
What Does the Market Think About Stryker? - 富途牛牛
Screener Results Flag Stryker Corporation as OversoldRisk Adjusted Technical Entry Plan Gains Followers - metal.it
스트라이커 (SYK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.01%
0.87%
자본화:
|
볼륨(24시간):